Cargando…
Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
Autores principales: | Ye, Shuai, Han, Yu, Pan, XiMin, Niu, KeXin, Liao, YuTing, Meng, XiaoChun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545842/ https://www.ncbi.nlm.nih.gov/pubmed/37795439 http://dx.doi.org/10.3389/fonc.2023.1283480 |
Ejemplares similares
-
Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022) -
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases
por: Giannini, Valentina, et al.
Publicado: (2022) -
Radiomics Analysis of Multiparametric MRI for Prediction of Synchronous Lung Metastases in Osteosarcoma
por: Luo, Zhendong, et al.
Publicado: (2022) -
Value of CT Radiomics and Clinical Features in Predicting Bone Metastases in Patients with NSCLC
por: Chen, Lu, et al.
Publicado: (2022) -
A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
por: Lin, Peng, et al.
Publicado: (2020)